Cargando…
Remimazolam in a Pediatric Patient With a Suspected Family History of Malignant Hyperthermia
Malignant hyperthermia (MH) is an acute hypermetabolic crisis, triggered in susceptible patients by the administration of succinylcholine or a volatile anesthetic agent. When providing anesthetic care for MH-susceptible patients, a total intravenous anesthetic technique with propofol or other sedati...
Autores principales: | Petkus, Holly, Willer, Brittany L., Tobias, Joseph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451561/ https://www.ncbi.nlm.nih.gov/pubmed/36128061 http://dx.doi.org/10.14740/jmc3977 |
Ejemplares similares
-
General anesthesia with remimazolam in a patient with clinically suspected malignant hyperthermia
por: Uchiyama, Keita, et al.
Publicado: (2021) -
Dexmedetomidine as the primary anesthetic agent during cardiac surgery in an infant with a family history of malignant hyperthermia
por: Naguib, Aymen, et al.
Publicado: (2011) -
Suspected Malignant Hyperthermia and the Application of a Multidisciplinary Response
por: Ebbitt, Laura, et al.
Publicado: (2020) -
Two cases of circulatory collapse due to suspected remimazolam anaphylaxis
por: Uchida, Satoshi, et al.
Publicado: (2022) -
A case report of suspected malignant hyperthermia where patient survived the episode
por: Iqbal, Asif, et al.
Publicado: (2017)